COG — Cambridge Cognition Holdings Share News
0.000.00%
- £16.06m
- £15.40m
- £13.52m
REG - Cambridge Cognition - £2.2m neurodegenerative disease trial contract
AnnouncementRCS - Cambridge Cognition - Alzheimer’s Disease Validation for NeuroVocalix
AnnouncementREG - Cambridge Cognition - Directorate Change
AnnouncementREG - Cambridge Cognition - PTSD trials with top 10 pharma company & US DoD
AnnouncementREG - Cambridge Cognition - Grant of Options
AnnouncementREG - Cambridge Cognition - Price Monitoring Extension
AnnouncementREG - Cambridge Cognition - Second Price Monitoring Extn
AnnouncementREG - Cambridge Cognition - Director/PDMR Share Purchases
AnnouncementREG - Cambridge Cognition - Trading Update and Notice of Results
AnnouncementREG - Cambridge Cognition - Price Monitoring Extension
AnnouncementREG - Cambridge Cognition - Second Price Monitoring Extn
AnnouncementREG - Cambridge Cognition - Holding(s) in Company
AnnouncementREG - Cambridge Cognition - Result of AGM
AnnouncementREG - Cambridge Cognition - Posting of Annual Report & Notice of AGM
AnnouncementREG - Cambridge Cognition - Results for the year ended 31 December 2021
AnnouncementREG - Cambridge Cognition - Senior Management Appointments
AnnouncementREG - Cambridge Cognition - Notice of Results
AnnouncementREG - Cambridge Cognition - Price Monitoring Extension
AnnouncementREG - Cambridge Cognition - Second Price Monitoring Extn
Announcement